What question did this study set out to answer?

This research investigates how the AGPAT3 protein influences tumor cell response to IFNγ-induced ferroptosis and modifies treatment efficacy.

March 13, 2026Open Access

AGPAT3 reshapes tumor cell vulnerability to IFNγ-mediated ferroptosis and enhances immunotherapy efficacy through lipid remodeling

Key Points

This research investigates how the AGPAT3 protein influences tumor cell response to IFNγ-induced ferroptosis and modifies treatment efficacy.
Examined the IFN-γ-IRF1-AGPAT3 signaling pathway
Utilized a ferroptosis-driver model prediction
Analyzed the impact of lipid remodeling on tumor cell vulnerability
Findings indicate that AGPAT3 alters tumor cell sensitivity to ferroptosis
Targeting the AGPAT3 pathway may enhance the effect of immunotherapeutic agents
Combination therapies show potential for improved patient outcomes

Abstract

The IFN-γ-IRF1-AGPAT3 axis represents an important antitumor mechanism that promotes ferroptosis. Targeting this pathway in combination with our ferroptosis-driver model prediction may improve ICI efficacy and patient outcomes.

AGPAT3 reshapes tumor cell vulnerability to IFNγ-mediated ferroptosis and enhances immunotherapy efficacy through lipid remodeling

Key Points

Abstract

Cite This Study